Left ventricular hypertrophy regression with antihypertensive treatment: focus on candesartan
- 1 January 2003
- journal article
- research article
- Published by Taylor & Francis in Blood Pressure
- Vol. 12 (sup2) , 5-15
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Change in cardiovascular risk profile by echocardiography in medium-risk elderly hypertensivesJournal of Human Hypertension, 2003
- Enhancing risk stratification in hypertensive subjects: how far should we go in routine screening for target organ damage?Journal Of Hypertension, 2002
- Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitorsJournal of the Renin-Angiotensin-Aldosterone System, 2000
- Impact of Different Partition Values on Prevalences of Left Ventricular Hypertrophy and Concentric Geometry in a Large Hypertensive PopulationHypertension, 2000
- Risk Mechanisms in Hypertensive Heart DiseaseHypertension, 1999
- Meta-analysis. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996)Nephrology Dialysis Transplantation, 1998
- Angiotensin II receptor antagonists: A new approach to blockade of the renin-angiotensin systemAmerican Heart Journal, 1994
- Cardiac function in systemic hypertension before and after reversal of left ventricular hypertrophyThe American Journal of Cardiology, 1988
- Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension.Hypertension, 1988
- The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertensionJACC, 1986